BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu R, Moise L, Tassone R, Gutierrez AH, Terry FE, Sangare K, Ardito MT, Martin WD, De Groot AS. H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance. Hum Vaccin Immunother 2015;11:2241-52. [PMID: 26090577 DOI: 10.1080/21645515.2015.1052197] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Richard G, De Groot AS, Steinberg GD, Garcia TI, Kacew A, Ardito M, Martin WD, Berdugo G, Princiotta MF, Balar AV, Sweis RF. Multi-step screening of neoantigens' HLA- and TCR-interfaces improves prediction of survival. Sci Rep 2021;11:9983. [PMID: 33976291 DOI: 10.1038/s41598-021-89016-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jang H, Meyers LM, Boyle C, De Groot AS, Moise L, Ross TM. Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge. Hum Vaccin Immunother 2020;16:2042-50. [PMID: 32783766 DOI: 10.1080/21645515.2020.1793711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Clemens EB, van de Sandt C, Wong SS, Wakim LM, Valkenburg SA. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Vaccines (Basel) 2018;6:E18. [PMID: 29587436 DOI: 10.3390/vaccines6020018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 12.8] [Reference Citation Analysis]
4 Moise L, Gutierrez A, Kibria F, Martin R, Tassone R, Liu R, Terry F, Martin B, De Groot AS. iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Hum Vaccin Immunother 2015;11:2312-21. [PMID: 26155959 DOI: 10.1080/21645515.2015.1061159] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
5 De Groot AS, Moise L, Terry F, Gutierrez AH, Hindocha P, Richard G, Hoft DF, Ross TM, Noe AR, Takahashi Y, Kotraiah V, Silk SE, Nielsen CM, Minassian AM, Ashfield R, Ardito M, Draper SJ, Martin WD. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Front Immunol 2020;11:442. [PMID: 32318055 DOI: 10.3389/fimmu.2020.00442] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
6 Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF. Highly conserved influenza T cell epitopes induce broadly protective immunity. Vaccine 2019;37:5371-81. [PMID: 31331771 DOI: 10.1016/j.vaccine.2019.07.033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
7 Watt WC, Cecil DL, Disis ML. Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer. Semin Immunopathol 2017;39:245-53. [PMID: 27975138 DOI: 10.1007/s00281-016-0596-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Kruiswijk C, Richard G, Salverda MLM, Hindocha P, Martin WD, De Groot AS, Van Riet E. In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance. Hum Vaccin Immunother 2020;16:277-85. [PMID: 31951773 DOI: 10.1080/21645515.2019.1703453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Moise L, M Biron B, Boyle CM, Kurt Yilmaz N, Jang H, Schiffer C, M Ross T, Martin WD, De Groot AS. T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response. Hum Vaccin Immunother 2018;14:2203-7. [PMID: 30015562 DOI: 10.1080/21645515.2018.1495303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Moise L, Beseme S, Tassone R, Liu R, Kibria F, Terry F, Martin W, De Groot AS. T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity. Expert Rev Vaccines 2016;15:607-17. [PMID: 26588466 DOI: 10.1586/14760584.2016.1123098] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
11 De Groot AS, Rosenberg AS, Miah SMS, Skowron G, Roberts BJ, Lélias S, Terry FE, Martin WD. Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses. Clin Immunol 2021;224:108661. [PMID: 33412295 DOI: 10.1016/j.clim.2020.108661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Horman WSJ, Nguyen THO, Kedzierska K, Bean AGD, Layton DS. The Drivers of Pathology in Zoonotic Avian Influenza: The Interplay Between Host and Pathogen. Front Immunol 2018;9:1812. [PMID: 30135686 DOI: 10.3389/fimmu.2018.01812] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
13 Koster J, Plasterk RHA. A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients. Sci Rep 2019;9:6577. [PMID: 31036835 DOI: 10.1038/s41598-019-42729-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
14 Kotraiah V, Phares TW, Terry FE, Hindocha P, Silk SE, Nielsen CM, Moise L, Tucker KD, Ashfield R, Martin WD, De Groot AS, Draper SJ, Gutierrez GM, Noe AR. Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization. Front Immunol 2021;12:690348. [PMID: 34305923 DOI: 10.3389/fimmu.2021.690348] [Reference Citation Analysis]
15 Gage E, Van Hoeven N, Dubois Cauwelaert N, Larsen SE, Erasmus J, Orr MT, Coler RN. Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization. Eur J Immunol 2019;49:266-76. [PMID: 30548475 DOI: 10.1002/eji.201847852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhu J, Kim J, Xiao X, Wang Y, Luo D, Jiang S, Chen R, Xu L, Zhang H, Moise L, Gutierrez AH, De Groot AS, Xiao G, Schoggins JW, Zhan X, Wang T, Xie Y. The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32908981 DOI: 10.1101/2020.02.08.939553] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Richard G, Princiotta MF, Bridon D, Martin WD, Steinberg GD, De Groot AS. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy. Expert Rev Vaccines 2021;:1-12. [PMID: 34882038 DOI: 10.1080/14760584.2022.2012456] [Reference Citation Analysis]
18 Hrdinová J, Verbij FC, Kaijen PHP, Hartholt RB, van Alphen F, Lardy N, Ten Brinke A, Vanhoorelbeke K, Hindocha PJ, De Groot AS, Meijer AB, Voorberg J, Peyron I. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ. Haematologica 2018;103:1083-92. [PMID: 29567779 DOI: 10.3324/haematol.2017.179119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y. A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines. Sci Rep 2017;7:1283. [PMID: 28455520 DOI: 10.1038/s41598-017-01372-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
20 Maine CJ, Richard G, Spasova DS, Miyake-Stoner SJ, Sparks J, Moise L, Sullivan RP, Garijo O, Choz M, Crouse JM, Aguilar A, Olesiuk MD, Lyons K, Salvador K, Blomgren M, DeHart JL, Kamrud KI, Berdugo G, De Groot AS, Wang NS, Aliahmad P. Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach. Mol Ther 2021;29:1186-98. [PMID: 33278563 DOI: 10.1016/j.ymthe.2020.11.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kim JI, Park S, Bae JY, Lee S, Kim J, Kim G, Yoo K, Heo J, Kim YS, Shin JS, Park MS, Park MS. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus. PLoS Biol 2020;18:e3001024. [PMID: 33362243 DOI: 10.1371/journal.pbio.3001024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Khan S, Parrillo M, Gutierrez AH, Terry FE, Moise L, Martin WD, De Groot AS. Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi. Hum Vaccin Immunother 2020;16:214-27. [PMID: 30614773 DOI: 10.1080/21645515.2018.1560772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 De Groot AS, Desai AK, Lelias S, Miah SMS, Terry FE, Khan S, Li C, Yi JS, Ardito M, Martin WD, Kishnani PS. Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease. Front Immunol 2021;12:636731. [PMID: 34220802 DOI: 10.3389/fimmu.2021.636731] [Reference Citation Analysis]
24 Cardenas-Garcia S, Ferreri L, Wan Z, Carnaccini S, Geiger G, Obadan AO, Hofacre CL, Rajao D, Perez DR. Maternally-Derived Antibodies Protect against Challenge with Highly Pathogenic Avian Influenza Virus of the H7N3 Subtype. Vaccines (Basel) 2019;7:E163. [PMID: 31671571 DOI: 10.3390/vaccines7040163] [Reference Citation Analysis]
25 Tan S, Gutiérrez AH, Gauger PC, Opriessnig T, Bahl J, Moise L, De Groot AS. Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013-2017. Vaccines (Basel) 2021;9:468. [PMID: 34066605 DOI: 10.3390/vaccines9050468] [Reference Citation Analysis]
26 Hu Z, Jiao X, Liu X. Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design. Front Microbiol 2017;8:1898. [PMID: 29018438 DOI: 10.3389/fmicb.2017.01898] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
27 De Groot AS, Moise L, Olive D, Einck L, Martin W. Agility in adversity: Vaccines on Demand. Expert Rev Vaccines 2016;15:1087-91. [PMID: 27389971 DOI: 10.1080/14760584.2016.1205951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 De Groot AS, Moise L. Innovation, urgency and acceptance at the 9th Vaccine Renaissance. Hum Vaccin Immunother 2016;12:3186-8. [PMID: 28010520 DOI: 10.1080/21645515.2016.1254853] [Reference Citation Analysis]